Concepedia

Publication | Closed Access

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

DOI

502

Citations

29

References

2006

Year

J. F. Wernicke, Yili Pritchett, Deborah N. D’Souza, A. Waninger, P. Tran, Satish Iyengar, Joel Raskin
Neurology

Abstract

This study confirms previous findings that duloxetine at 60 mg QD and 60 mg BID is effective and safe in the management of diabetic peripheral neuropathic pain.

References

YearCitations

Page 1